INVASIVE FUNGAL DISEASE
Clinical trials for INVASIVE FUNGAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new INVASIVE FUNGAL DISEASE trials appear
Sign up with your email to follow new studies for INVASIVE FUNGAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug may block deadly fungal infections
Disease control CompletedThis study tested a new drug called rezafungin to prevent serious fungal infections in 602 adults receiving a bone marrow transplant. Participants received either rezafungin or the standard antifungal treatment. The goal was to see if rezafungin is safer and more effective at kee…
Matched conditions: INVASIVE FUNGAL DISEASE
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
ICU study explores cutting back on antifungals for vulnerable patients
Knowledge-focused CompletedThis study looked at whether it is safe to reduce or stop antifungal drugs early in immunocompromised patients in the ICU who are being treated for a suspected candida infection. Researchers tracked 275 patients across 14 ICUs to see how often treatment was reduced and what facto…
Matched conditions: INVASIVE FUNGAL DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 17, 2026 02:54 UTC
-
PET scans tested to guide therapy for hidden fungal infection
Knowledge-focused CompletedThis study looked at whether a special scan (PET scan) can help doctors decide the best treatment for a rare fungal infection of the liver and spleen in people with blood cancer. One hundred adults who had recently recovered from low white blood cell counts and had suspicious spo…
Matched conditions: INVASIVE FUNGAL DISEASE
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC